• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Galoob Toys

Galoob Toys

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Amgen likely aiming to meet, not beat, first-quarter earnings expectations

    Amgen likely aiming to meet, not beat, first-quarter earnings expectations

  2. Pricey rare disease drug's launch will be likely focus of Biogen earnings

    Pricey rare disease drug's launch will be likely focus of Biogen earnings

  3. UPDATE: Why Teva stock isn't moving on its major Huntington's disease drug approval

    UPDATE: Why Teva stock isn't moving on its major Huntington's disease drug approval

  4. UPDATE: Here's how much Mylan's U.S. EpiPen recall could cost it

    UPDATE: Here's how much Mylan's U.S. EpiPen recall could cost it

  5. UPDATE: These corporate ties will be on display at Scott Gottlieb's FDA commissioner confirmation hearing today

    UPDATE: These corporate ties will be on display at Scott Gottlieb's FDA commissioner confirmation hearing today

  6. UPDATE: Mylan's EpiPen recall likely to have low U.S. revenue impact: EvercoreISI analyst

    UPDATE: Mylan's EpiPen recall likely to have low U.S. revenue impact: EvercoreISI analyst

  7. Here's how much Mylan's U.S. EpiPen recall could cost it

    Here's how much Mylan's U.S. EpiPen recall could cost it

  8. UPDATE: Trump is golfing twice as much as Obama did

    UPDATE: Trump is golfing twice as much as Obama did

  9. UPDATE: Why investors aren't more excited about Regeneron's new $37,000-a-year drug

    UPDATE: Why investors aren't more excited about Regeneron's new $37,000-a-year drug

  10. AVer Releases ULTRA HD 4K CAM340 for Highest Quality Experience in Huddle Rooms Running Zoom

    AVer Releases ULTRA HD 4K CAM340 for Highest Quality Experience in Huddle Rooms Running Zoom

123

©2017 Morningstar Advisor. All right reserved.